Published in Gene Therapy Weekly, June 29th, 1998
A United Kingdom research group Axis Genetics Plc said development of a new generation of edible vaccines derived from genetically-altered plants had moved a step nearer through an agreement with the U.S.-based Boyce Thompson Institute (BTI) for Plant Research.
Axis and BTI believe by altering plant viruses and the genetic make up of fruit and vegetables they can provoke the body's natural defences against attack from a raft of viruses and bacteria.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1998-06-29)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.